Two relatively new but increasingly used diabetes drugs (with one of these classes also now approved for used in heart failure in people with or without diabetes) are possibly more effective in people with an Asian background ...
Mar 12, 2021
0
13
More than five years after receiving an experimental immunotherapy drug, half of a group of people at high risk of developing Type 1 diabetes remained disease-free compared with 22% of those who received a placebo, according ...
Mar 3, 2021
0
52
Diabetic patients taking the natural product goldenseal while taking the prescription drug metformin may be unwittingly sabotaging their efforts to maintain healthy blood glucose levels. This concern arose from a recent study ...
Feb 8, 2021
0
12
Diabetes is a known risk factor for morbidity and mortality related to COVID-19. In diabetes patients, rare but severe complications, like the potentially lethal condition diabetic ketoacidosis (DKA), can arise when illness ...
Dec 28, 2020
0
21
With nearly 2 million Americans battling type 1 diabetes, it is no surprise that clinical therapies for the disease are constantly evolving and improving. In type 1 diabetes mellitus, the body's immune system attacks and ...
Dec 16, 2020
0
39
An international research group has clarified the action mechanism of incretin-based drugs in the treatment of diabetes. The research group headed by Professor Seino Susumu included Researcher Okechi Oduori et al. (Division ...
Nov 25, 2020
0
4
Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes in an entirely new way. Since that time, evidence in favor of the use of sodium/glucose cotransporter 2 (SGLT2) inhibitors ...
Nov 17, 2020
0
18
Analysis of data from a dedicated heart failure registry reveals four out of five patients with heart failure with reduced ejection fraction (HFrEF) could be considered for treatment with dapagliflozin, an sodium glucose ...
Nov 16, 2020
0
2
Empagliflozin, a recently developed diabetes drug, can effectively treat and reverse heart failure in both diabetic and non-diabetic patients, according to researchers at the Icahn School of Medicine at Mount Sinai.
Nov 13, 2020
0
14
Metformin is a common type 2 diabetes drug. Recently, it was found to extend life span of young non-diabetic animals but the responses of older organisms to metformin remain unexplored. Researchers at the Leibniz Institute ...
Nov 12, 2020
1
302
